These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22234330)

  • 41. Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain and Trypanosoma brucei Inhibitors.
    Giroud M; Dietzel U; Anselm L; Banner D; Kuglstatter A; Benz J; Blanc JB; Gaufreteau D; Liu H; Lin X; Stich A; Kuhn B; Schuler F; Kaiser M; Brun R; Schirmeister T; Kisker C; Diederich F; Haap W
    J Med Chem; 2018 Apr; 61(8):3350-3369. PubMed ID: 29590750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxoplasma gondii cathepsin L is the primary target of the invasion-inhibitory compound morpholinurea-leucyl-homophenyl-vinyl sulfone phenyl.
    Larson ET; Parussini F; Huynh MH; Giebel JD; Kelley AM; Zhang L; Bogyo M; Merritt EA; Carruthers VB
    J Biol Chem; 2009 Sep; 284(39):26839-50. PubMed ID: 19596863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei.
    Vodnala M; Fijolek A; Rofougaran R; Mosimann M; Mäser P; Hofer A
    J Biol Chem; 2008 Feb; 283(9):5380-8. PubMed ID: 18167353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Probing the cruzain S2 recognition subsite: a kinetic and binding energy calculation study.
    Polticelli F; Zaini G; Bolli A; Antonini G; Gradoni L; Ascenzi P
    Biochemistry; 2005 Mar; 44(8):2781-9. PubMed ID: 15723522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C-Terminal extension of a plant cysteine protease modulates proteolytic activity through a partial inhibitory mechanism.
    Dutta S; Choudhury D; Dattagupta JK; Biswas S
    FEBS J; 2011 Sep; 278(17):3012-24. PubMed ID: 21707922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-guided development of selective TbcatB inhibitors.
    Mallari JP; Shelat AA; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK
    J Med Chem; 2009 Oct; 52(20):6489-93. PubMed ID: 19769357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of recombinant Entamoeba histolytica cysteine proteinase 1 to identify a potent inhibitor of amebic invasion in a human colonic model.
    Meléndez-López SG; Herdman S; Hirata K; Choi MH; Choe Y; Craik C; Caffrey CR; Hansell E; Chávez-Munguía B; Chen YT; Roush WR; McKerrow J; Eckmann L; Guo J; Stanley SL; Reed SL
    Eukaryot Cell; 2007 Jul; 6(7):1130-6. PubMed ID: 17513563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium.
    Hansen G; Heitmann A; Witt T; Li H; Jiang H; Shen X; Heussler VT; Rennenberg A; Hilgenfeld R
    Structure; 2011 Jul; 19(7):919-29. PubMed ID: 21742259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trypanosoma brucei brucei oligopeptidase B null mutants display increased prolyl oligopeptidase-like activity.
    Kangethe RT; Boulangé AF; Coustou V; Baltz T; Coetzer TH
    Mol Biochem Parasitol; 2012; 182(1-2):7-16. PubMed ID: 22123425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Understanding Structure-Activity Relationships for Trypanosomal Cysteine Protease Inhibitors by Simulations and Free Energy Calculations.
    Santos LH; Waldner BJ; Fuchs JE; Pereira GAN; Liedl KR; Caffarena ER; Ferreira RS
    J Chem Inf Model; 2019 Jan; 59(1):137-148. PubMed ID: 30532974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteases from Trypanosoma brucei brucei. Purification, characterisation and interactions with host regulatory molecules.
    Troeberg L; Pike RN; Morty RE; Berry RK; Coetzer TH; Lonsdale-Eccles JD
    Eur J Biochem; 1996 Jun; 238(3):728-36. PubMed ID: 8706674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits.
    Martinez-Mayorga K; Byler KG; Ramirez-Hernandez AI; Terrazas-Alvares DE
    Drug Discov Today; 2015 Jul; 20(7):890-8. PubMed ID: 25697479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression and substrate specificity of a recombinant cysteine proteinase B of Leishmania braziliensis.
    Lanfranco MF; Loayza-Muro R; Clark D; Núñez R; Zavaleta AI; Jimenez M; Meldal M; Coombs GH; Mottram JC; Izidoro M; Juliano MA; Juliano L; Arévalo J
    Mol Biochem Parasitol; 2008 Oct; 161(2):91-100. PubMed ID: 18639590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense.
    Caffrey CR; Hansell E; Lucas KD; Brinen LS; Alvarez Hernandez A; Cheng J; Gwaltney SL; Roush WR; Stierhof YD; Bogyo M; Steverding D; McKerrow JH
    Mol Biochem Parasitol; 2001 Nov; 118(1):61-73. PubMed ID: 11704274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cloning, expression, purification and activity assay of Trypanosoma brucei phenylalanyl-tRNA synthetase in Escherichia coli].
    Yao Y; Gao G; Li D
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):130-5. PubMed ID: 20353103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Independent amino acid residues in the S2 pocket of falcipain-3 determine its specificity for P2 residues in substrates.
    Kolla VK; Prasad R; Sayyad Z; Atul ; Shah AY; Allanki AD; Navale R; Singhal N; Tanneru N; Sudhakar R; Venkatesan V; Deshmukh MV; Sijwali PS
    Mol Biochem Parasitol; 2015 Aug; 202(2):11-22. PubMed ID: 26439304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
    Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
    Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L.
    Freitas RF; Oprea TI; Montanari CA
    Bioorg Med Chem; 2008 Jan; 16(2):838-53. PubMed ID: 17996450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substrate inhibition of cruzipain is not affected by the C-terminal domain.
    Stoka V; McKerrow JH; Cazzulo JJ; Turk V
    FEBS Lett; 1998 Jun; 429(2):129-33. PubMed ID: 9650575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.